This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. (INO) slipped 4.44% to $2.15 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.57% to 23,561.84 and the Dow Jones Industrial Average  rising 0.16% to 48,442.41.
This was the stock's fourth consecutive day of losses.
Inovio Pharmaceuticals Inc. closed 27.83% below its 52-week high of $2.98, which the company reached on September 9th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson &amp; Johnson (JNJ) fell 0.74% to $205.78, Statera Biopharma Inc. (STAB) rose 50.00% to $0.00, and Pfizer Inc. (PFE) fell 1.31% to $24.88.
Trading volume (2.2 M) eclipsed its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 23, 2025.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-23-25 1726ET

<p>Shares of Inovio Pharmaceuticals Inc. (INO) fell 4.44% to $2.15 on Tuesday, underperforming compared to competitors. This marked the stock's fourth consecutive day of losses, closing 27.83% below its 52-week high. Trading volume was 2.2 million, higher than the 50-day average of 1.3 million.</p>

Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors